author-photo

Rebecca L. Riding

University of Massachusetts Medical School

4

Papers

49

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma.

2021 Journal of Experimental Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy.

2020 Pigment Cell & Melanoma Research
Show All
- Source
- Cite
- Save
Citations (1)
The Role of Memory CD8+ T Cells in Vitiligo

2019 Journal of Immunology
- Rebecca L. Riding
- John E. Harris
Show All
- Source
- Cite
- Save
Citations (41)